Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Disc Medicine, Inc. - Common Stock (NQ: IRON )

45.96 +0.56 (+1.23%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 381,915
Open 45.68
Bid (Size) 43.95 (1)
Ask (Size) 47.98 (1)
Prev. Close 45.40
Today's Range 44.65 - 46.26
52wk Range 25.60 - 77.60
Shares Outstanding 5,000,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
S&P 500 Edges Lower; RH Shares Plunge After Q1 Results
Via Benzinga
Topics Stocks
Exposures US Equities
Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga

Performance

YTD
-23.05%
-23.05%
1 Month
+4.03%
+4.03%
3 Month
+70.35%
+70.35%
6 Month
-32.60%
-32.60%
1 Year
+0.77%
+0.77%

More News

Read More
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Gold Gains 1%; US Consumer Sentiment Falls In June
Via Benzinga
Hasbro, Tutor Perini, Arm Holdings And Other Big Stocks Moving Higher On Friday
Via Benzinga
Disc Medicine Announces Underwritten Offering of Common Stock
From Disc Medicine Inc
Via GlobeNewswire
Disc Medicine Presents Positive Clinical Data Across Portfolio at the European Hematology Association (EHA) 2024 Congress
From Disc Medicine Inc
Via GlobeNewswire
Disc Medicine to Participate in the Jefferies Global Healthcare Conference
From Disc Medicine Inc
Via GlobeNewswire
Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2024 Congress
From Disc Medicine Inc
Via GlobeNewswire
Disc Medicine to Participate in the H.C. Wainwright BioConnect Investor Conference
From Disc Medicine Inc
Via GlobeNewswire
IRON Stock Earnings: Disc Medicine Misses EPS for Q1 2024
Via InvestorPlace
Disc Medicine Reports First Quarter 2024 Financial Results and Provides Business Update
From Disc Medicine Inc
Via GlobeNewswire
Top 3 Health Care Stocks You'll Regret Missing This Month
Via Benzinga
Gold Gains 1%; CXApp Shares Spike Higher
Via Benzinga
Topics Stocks
Exposures US Equities
Why Nuvve Holding Shares Are Trading Lower By Around 30%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Crude Oil Moves Higher; Oxford Industries Shares Fall After Q4 Results
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Disc Medicine Stock Plunges As Light Sensitivity Treatment Data Confounded Due To Outsized Placebo Response
Via Benzinga
Disc Medicine Plummets 59% After Placebo Effect Confounds Sunlight Sensitivity Study
Via Investor's Business Daily
Disc Reports Topline Results from Phase 2 AURORA Study of Bitopertin in Patients with Erythropoietic Protoporphyria (EPP)
From Disc Medicine Inc
Via GlobeNewswire
Disc Medicine Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
From Disc Medicine Inc
Via GlobeNewswire
Disc Medicine to Participate in the Leerink Partners Global Biopharma Conference 2024
From Disc Medicine Inc
Via GlobeNewswire
Week In Review: Mabwell Sells Ex-China Rights To Rare Disease Therapy In $412 Million Deal
Via Talk Markets
Disc Medicine Expands Leadership Team with Appointment of Industry Veteran Pamela Stephenson, MPH as Chief Commercial Officer
From Disc Medicine Inc
Via GlobeNewswire
Disc Medicine Receives FDA Fast Track Designation for DISC-0974 for the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease
From Disc Medicine Inc
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.